Metformin induced Bullous pemphigoid - A Rare Case Report
DOI:
https://doi.org/10.66344/jpad.v31i4.1780Abstract
Bullous Pemphigoid (BP) is a chronic, acquired autoimmune skin disease. Exact etiology of this autoimmune process is not known. Certain drugs such as furosemide, penicillins, sulfonamides, ciprofloxacin, penicillamines, Angiotensin Converting Enzyme(ACE) inhibitors, chloroquine, etanercept, and phenacetin were reported to cause BP. Metformin is also a rarer one to cause BP. This is a case report of a 58-year-old female recently diagnosed with Type 2 Diabetes Mellitus (T2DM), started on Metformin, presented with the formation of few cutaneous tense bullae on both distal forearm. Clinical finding of skin lesions and direct immunofluorescence (DIF) finding were consistent with BP. To our best knowledge, this is among the very few cases of Metformin induced BP in the literature.
References
1. Nishie W. Update on the pathogenesis of bullous pemphigoid: an autoantibody-mediated blistering disease targeting collagen XVII. J Dermatol Sci. 2014;73:179-86.
2. Tan CW, Pang Y, Sim B, Thirumoorthy T et al. The association between drugs and bullous pemphigoid. Br J Dermatol.2017; 176:549-51.
3. Stavropoulos, Panagiotis, Efthymia Soura, Christina Antoniou. Drug-induced pemphigoid: A review of the literature. J Eur Acad Dermatol Venereol.2014;28: 1133-40.
4. Khandpur, Sujay, Parul Verma. Bullous pemphigoid. Indian J Dermatol Venereol Leprol.2011;77:450-5.
5. Mukherjee, Sudeb. Metformin induced bullous pemphigoid, the first case. Int J Sci Rep.2015;1:184-6.
6. Attaway, Amy, Tracey Liu. Mersfelder, Sakshi Vaishnav and Joanne K. Baker. Bullous pemphigoid associated with dipeptidase inhibitors. A case report and review of literature. J Dermatol Case Rep.2014;8:24-8.
7. Huilgol SC, Bhogal BS, Black MM. Immunofluorescence of the immunobullous
disorders Part two: The clinical disorders. Indian J Dermatol Venereol Leprol.1995;61:255-64.
8. Skandalis K, Spirova M, Gaitanis G, Tsartsarakis A, Bassukas ID. Drug-induced bullous pemphigoid in diabetes mellitus patients receiving dipeptidyl peptidase-IV inhibitors plus metformin. J Eur Acad Dermatol Venereol.2012;26:249–53.
9. Fontaine J. Treatment of bullous pemphigoid. J Dermatol 2003;30:83-90.
10. Wojnarowska F. Guidelines for the management of bullous pemphigoid. Br J Dermatol.2002;147:214-21.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Nitesh R. Pokharel
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
